Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

VL. Patel, EL. Busch, TM. Friebel, A. Cronin, G. Leslie, L. McGuffog, J. Adlard, S. Agata, BA. Agnarsson, M. Ahmed, K. Aittomäki, E. Alducci, IL. Andrulis, A. Arason, N. Arnold, G. Artioli, B. Arver, B. Auber, J. Azzollini, J. Balmaña, RB....

. 2020 ; 80 (3) : 624-638. [pub] 20191113

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural, práce podpořená grantem, Research Support, U.S. Gov't, Non-P.H.S.

Perzistentní odkaz   https://www.medvik.cz/link/bmc20025213

Grantová podpora
203477/Z/16/Z Wellcome Trust - United Kingdom
CRN-87521 CIHR - Canada
C1287/A 10710 Cancer Research UK - United Kingdom
P50 CA116201 NCI NIH HHS - United States
R01 CA149429 NCI NIH HHS - United States
U19 CA148065 NCI NIH HHS - United States
C1281/A12014 Cancer Research UK - United Kingdom
U10 CA180822 NCI NIH HHS - United States
U10 CA180868 NCI NIH HHS - United States
R03 CA130065 NCI NIH HHS - United States
R01 CA176785 NCI NIH HHS - United States
CRN-87521 CIHR - Canada
RC4 CA153828 NCI NIH HHS - United States
P20 CA233255 NCI NIH HHS - United States
R01 CA142996 NCI NIH HHS - United States
R01 CA140323 NCI NIH HHS - United States
P50 CA125183 NCI NIH HHS - United States
UM1 CA164920 NCI NIH HHS - United States
P30 CA168524 NCI NIH HHS - United States
U01 CA161032 NCI NIH HHS - United States
C12292/A11174 Cancer Research UK - United Kingdom
U10 CA027469 NCI NIH HHS - United States
C5047/A10692 Cancer Research UK - United Kingdom
UL1 TR000124 NCATS NIH HHS - United States
U01 CA116167 NCI NIH HHS - United States
C5047/A8384 Cancer Research UK - United Kingdom
P30 CA008748 NCI NIH HHS - United States
R01 CA214545 NCI NIH HHS - United States
C5047/A8385FCCC Cancer Research UK - United Kingdom
R01 CA128978 NCI NIH HHS - United States
U19 CA148537 NCI NIH HHS - United States
P30 CA051008 NCI NIH HHS - United States
R01 CA116167 NCI NIH HHS - United States
C12292/A20861 Cancer Research UK - United Kingdom
U10 CA037517 NCI NIH HHS - United States
P20 GM130423 NIGMS NIH HHS - United States
R25 CA112486 NCI NIH HHS - United States
C5047/A15007 Cancer Research UK - United Kingdom
N02CP65504 NCI NIH HHS - United States
P50 CA105641 NCI NIH HHS - United States
T32 CA009001 NCI NIH HHS - United States
U19 CA148112 NCI NIH HHS - United States
C8197/A16565 Cancer Research UK - United Kingdom
10118 Cancer Research UK - United Kingdom
R01 CA192393 NCI NIH HHS - United States
C12292/A11174 Cancer Research UK - United Kingdom
N02CP11019 NCI NIH HHS - United States

Pathogenic sequence variants (PSV) in BRCA1 or BRCA2 (BRCA1/2) are associated with increased risk and severity of prostate cancer. We evaluated whether PSVs in BRCA1/2 were associated with risk of overall prostate cancer or high grade (Gleason 8+) prostate cancer using an international sample of 65 BRCA1 and 171 BRCA2 male PSV carriers with prostate cancer, and 3,388 BRCA1 and 2,880 BRCA2 male PSV carriers without prostate cancer. PSVs in the 3' region of BRCA2 (c.7914+) were significantly associated with elevated risk of prostate cancer compared with reference bin c.1001-c.7913 [HR = 1.78; 95% confidence interval (CI), 1.25-2.52; P = 0.001], as well as elevated risk of Gleason 8+ prostate cancer (HR = 3.11; 95% CI, 1.63-5.95; P = 0.001). c.756-c.1000 was also associated with elevated prostate cancer risk (HR = 2.83; 95% CI, 1.71-4.68; P = 0.00004) and elevated risk of Gleason 8+ prostate cancer (HR = 4.95; 95% CI, 2.12-11.54; P = 0.0002). No genotype-phenotype associations were detected for PSVs in BRCA1. These results demonstrate that specific BRCA2 PSVs may be associated with elevated risk of developing aggressive prostate cancer. SIGNIFICANCE: Aggressive prostate cancer risk in BRCA2 mutation carriers may vary according to the specific BRCA2 mutation inherited by the at-risk individual.

2nd Department of Medical Oncology EUROMEDICA General Clinic of Thessaloniki Aristotle University of Thessaloniki School of Medicine Thessaloniki Greece

Cancer Research Initiatives Foundation Sime Darby Medical Centre Subang Jaya Selangor Malaysia

Cancer Research Malaysia Subang Jaya Selangor Malaysia Breast Cancer Research Unit Cancer Research Institute University Malaya Medical Centre Kuala Lumpur Malaysia

Cancer Risk Factors and Life Style Epidemiology Unit Institute for Cancer Research Prevention and Clinical Network Florence Italy

Cancer Sciences Academic Unit Faculty of Medicine University of Southampton Southampton United Kingdom

Center for Clinical Cancer Genetics The University of Chicago Chicago Illinois

Center for Genomic Medicine Rigshospitalet Copenhagen University Hospital Copenhagen Denmark

Center for Integrated Oncology University of Cologne Cologne Germany Center for Hereditary Breast and Ovarian Cancer University Hospital of Cologne Cologne Germany

Center for Medical Genetics NorthShore University HealthSystem Evanston Illinois The University of Chicago Pritzker School of Medicine Chicago Illinois

Center for Molecular Medicine Cologne University of Cologne Cologne Germany Center for Hereditary Breast and Ovarian Cancer University Hospital of Cologne Cologne Germany

Centre for Cancer Genetic Epidemiology Department of Public Health and Primary Care University of Cambridge Cambridge United Kingdom

Centre for Cancer Genetic Epidemiology Department of Public Health and Primary Care University of Cambridge Cambridge United Kingdom Centre for Cancer Genetic Epidemiology Department of Oncology University of Cambridge Cambridge United Kingdom

Centre for Epidemiology and Biostatistics Melbourne School of Population and Global Health The University of Melbourne Melbourne Victoria Australia

Centre for Medical Genetics Ghent University Ghent Belgium

Centre of Familial Breast and Ovarian Cancer Department of Medical Genetics Institute of Human Genetics University of Würzburg Würzburg Germany

Clinical Cancer Genetics City of Hope Duarte California

Clinical Cancer Genetics Program Division of Human Genetics Department of Internal Medicine The Comprehensive Cancer Center The Ohio State University Columbus Ohio

Clinical Genetic Unit Department of Paediatrics Zealand University Hospital Roskilde Denmark

Clinical Genetics Amsterdam UMC Vrije Universiteit Amsterdam Amsterdam the Netherlands

Clinical Genetics Branch Division of Cancer Epidemiology and Genetics National Cancer Institute Bethesda Maryland

Clinical Genetics Department St Michael's Hospital Bristol United Kingdom

Clinical Genetics Guy's and St Thomas' NHS Foundation Trust London United Kingdom

Clinical Genetics Karolinska Institutet Stockholm Sweden

Clinical Genetics Research Lab Department of Cancer Biology and Genetics Memorial Sloan Kettering Cancer Center New York New York

Clinical Genetics Service Department of Medicine Memorial Sloan Kettering Cancer Center New York New York

Dana Farber Cancer Institute Boston Massachusetts

Département d'Hématologie Oncologie Médicale Centre Antoine Lacassagne Nice France

Department of Breast Medical Oncology and Clinical Genetics Program University of Texas MD Anderson Cancer Center Houston Texas

Department of Cancer Biology and Genetics The Ohio State University Columbus Ohio

Department of Cancer Epidemiology and Genetics Masaryk Memorial Cancer Institute Brno Czech Republic

Department of Chemotherapy National Institute of Oncology Budapest Hungary

Department of Clinical Genetics Aalborg University Hospital Aalborg Denmark

Department of Clinical Genetics Aarhus University Hospital Aarhus Denmark

Department of Clinical Genetics Alder Hey Hospital Liverpool United Kingdom

Department of Clinical Genetics Fox Chase Cancer Center Philadelphia Pennsylvania

Department of Clinical Genetics Helsinki University Hospital University of Helsinki Helsinki Finland

Department of Clinical Genetics Leiden University Medical Center Leiden the Netherlands

Department of Clinical Genetics Lund University Hospital Lund Sweden

Department of Clinical Genetics Maastricht University Medical Center Maastricht the Netherlands

Department of Clinical Genetics Odense University Hospital Odense Denmark

Department of Clinical Genetics Rigshospitalet Copenhagen Denmark

Department of Clinical Genetics Royal Devon and Exeter Hospital Exeter United Kingdom

Department of Clinical Genetics South Glasgow University Hospitals Glasgow United Kingdom

Department of Clinical Genetics Vejle Hospital Vejle Denmark

Department of Clinical Genetics VU University Medical Center Amsterdam the Netherlands

Department of Dermatology Huntsman Cancer Institute University of Utah School of Medicine Salt Lake City Utah

Department of Epidemiology The Netherlands Cancer Institute Amsterdam the Netherlands

Department of Genetics and Computational Biology QIMR Berghofer Medical Research Institute Brisbane Queensland Australia

Department of Genetics Portuguese Oncology Institute Porto Portugal

Department of Genetics Portuguese Oncology Institute Porto Portugal Biomedical Sciences Institute University of Porto Porto Portugal

Department of Gynaecology and Obstetrics University Hospital of Schleswig Holstein Campus Kiel Christian Albrechts University Kiel Kiel Germany

Department of Gynaecology and Obstetrics University Hospital Ulm Ulm Germany

Department of Gynecology and Obstetrics Ludwig Maximilian University of Munich Munich Germany

Department of Gynecology and Obstetrics Technical University of Dresden Dresden Germany

Department of Gynecology and Obstetrics University Hospital Düsseldorf Heinrich Heine University Düsseldorf Düsseldorf Germany

Department of Human Genetics Radboud University Medical Center Nijmegen the Netherlands

Department of Internal Medicine Division of Oncology University of Kansas Medical Center Westwood Kansas

Department of Laboratory Medicine and Pathobiology University of Toronto Toronto Ontario Canada Laboratory Medicine Program University Health Network Toronto Ontario Canada

Department of Laboratory Medicine and Pathology Mayo Clinic Rochester Minnesota

Department of Medical and Biological Sciences University of Udine Udine Italy

Department of Medical Genetics University Medical Center Utrecht the Netherlands

Department of Medical Oncology Beth Israel Deaconess Medical Center Boston Massachusetts

Department of Medical Oncology Family Cancer Clinic Erasmus MC Cancer Institute Rotterdam the Netherlands

Department of Medicine Abramson Cancer Center Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania

Department of Medicine Huntsman Cancer Institute Salt Lake City Utah

Department of Molecular Genetics National Institute of Oncology Budapest Hungary

Department of Molecular Medicine and Surgery Karolinska Institutet Stockholm Sweden Department of Clinical Genetics Karolinska University Hospital Stockholm Sweden

Department of Molecular Medicine University La Sapienza Rome Italy

Department of OB GYN Medical University of Vienna Vienna Austria

Department of Obstetrics and Gynecology Helsinki University Hospital University of Helsinki Helsinki Finland

Department of Oncology and Haematology University of Modena and Reggio Emilia Modena Italy

Department of Oncology Hospital Clinico San Carlos IdISSC Madrid Spain

Department of Oncology Karolinska Institutet Stockholm Sweden

Department of Oncology Landspitali University Hospital Reykjavik Iceland

Department of Oncology Lund University and Skåne University Hospital Lund Sweden

Department of Oncology Mayo Clinic Rochester Minnesota

Department of Oncology Rigshospitalet Copenhagen University Hospital Copenhagen Denmark

Department of Pathology and Laboratory Medicine Kansas University Medical Center Kansas City Kansas

Department of Pathology Landspitali University Hospital 101 Reykjavik Iceland BMC Faculty of Medicine University of Iceland Reykjavik Iceland

Department of Pathology Landspitali University Hospital 101 Reykjavik Iceland School of Medicine University of Iceland Reykjavik Iceland

Department of Population Sciences Beckman Research Institute of City of Hope Duarte California

Department of Preventive Medicine Gacheon University College of Medicine Incheon Republic of Korea

Department of Preventive Medicine Seoul National University College of Medicine Seoul Korea Department of Biomedical Sciences Seoul National University Graduate School Seoul Korea Cancer Research Institute Seoul National University Seoul Korea

Department of Radiation Oncology Dana Farber Cancer Institute and Brigham and Women's Hospital Boston Massachusetts

Department of Surgery Daerim Saint Mary's Hospital Seoul Korea

Department of Surgery Seoul National University Bundang Hospital Seongnam Korea

Department of Surgery Seoul National University Bundang Hospital Seongnam Korea Clinical Genetics Service Department of Medicine Memorial Sloan Kettering Cancer Center New York New York

Department of Surgery Soonchunhyang University Bucheon Hospital Bucheon Korea

Department of Surgery Soonchunhyang University College of Medicine and Soonchunhyang University Hospital Seoul Korea

Department of Surgery The University of Hong Kong Pok Fu Lam Hong Kong

Department of Surgery Ulsan University College of Medicine and Asan Medical Center Seoul Korea

Department of Urology Medical University of Vienna Vienna Austria

Department of Women's Health Tubingen University Hospital Tubingen Germany

Departments of Pediatrics and Medicine Columbia University New York New York

Dept of OB GYN and Comprehensive Cancer Center Medical University of Vienna Vienna Austria

Division of Cancer Prevention and Genetics IEO European Institute of Oncology IRCCS Milan Italy

Division of Evolution and Genomic Medicine School of Biological Sciences Faculty of Biology Medicine and Health and Manchester Academic Health Science Centre University of Manchester Manchester United Kingdom Manchester Centre for Genomic Medicine St Mary's Hospital Central Manchester University Hospitals NHS Foundation Trust and Manchester Academic Health Science Centre Manchester United Kingdom

Division of Functional Onco genomics and Genetics Centro di Riferimento Oncologico di Aviano IRCCS Aviano Italy

Division of Gynaecology and Obstetrics Klinikum rechts der Isar der Technischen Universität München Munich Germany

Division of Oncology Department of Medicine Stanford Cancer Institute Stanford University School of Medicine Stanford California

Family Cancer Clinic The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital Amsterdam the Netherlands

Fred A Litwin Center for Cancer Genetics Lunenfeld Tanenbaum Research Institute of Mount Sinai Hospital Toronto Ontario Canada

Fred A Litwin Center for Cancer Genetics Lunenfeld Tanenbaum Research Institute of Mount Sinai Hospital Toronto Ontario Canada Department of Molecular Genetics University of Toronto Toronto Ontario Canada

Genetic Counseling Unit Hereditary Cancer Program IDIBELL Catalan Institute of Oncology CIBERONC Barcelona Spain

Genetic Counseling Unit Hereditary Cancer Program IDIBGI Catalan Institute of Oncology CIBERONC Girona Spain

Genome Diagnostics Program IFOM the FIRC Institute of Molecular Oncology Milan Italy

Genomics Center Centre Hospitalier Universitaire de Québec Université Laval Research Centre Québec City Québec Canada

Harvard T H Chan School of Public Health Boston Massachusetts Channing Division of Network Medicine Department of Medicine Brigham and Women's Hospital Harvard Medical School Boston Massachusetts

Harvard T H Chan School of Public Health Boston Massachusetts Dana Farber Cancer Institute Boston Massachusetts

Hematology Oncology and Transfusion Medicine Center Department of Molecular and Regenerative Medicine Vilnius University Hospital Santariskiu Clinics Vilnius Lithuania

High Risk and Cancer Prevention Group Vall d'Hebron Institute of Oncology University Hospital Vall d'Hebron Barcelona Spain

Hong Kong Hereditary Breast Cancer Family Registry Cancer Genetics Centre Happy Valley Hong Kong

Hong Kong Hereditary Breast Cancer Family Registry Cancer Genetics Centre Happy Valley Hong Kong Department of Pathology Hong Kong Sanatorium and Hospital Happy Valley Hong Kong

Hong Kong Hereditary Breast Cancer Family Registry Cancer Genetics Centre Happy Valley Hong Kong Department of Surgery The University of Hong Kong Pok Fu Lam Hong Kong Department of Surgery Hong Kong Sanatorium and Hospital Happy Valley Hong Kong

Human Cancer Genetics Programme Spanish National Cancer Research Centre Madrid Spain

Human Genetics Group Spanish National Cancer Research Centre Madrid Spain

Immunology and Molecular Oncology Unit Veneto Institute of Oncology IOV IRCCS Padua Italy

INBIOMED Faculty of Medicine CONICET and CEMIC Department of Clinical Chemistry Medical Direction University of Buenos Aires Buenos Aires Argentina

Institute for Medical Genetics and Human Genetics Charité Universitätsmedizin Berlin corporate member of Freie Universität Berlin Humboldt Universität zu Berlin and Berlin Institute of Health Berlin Germany

Institute for Medical Informatics Statistics and Epidemiology University of Leipzig Leipzig Germany LIFE Leipzig Research Centre for Civilization Diseases University of Leipzig Leipzig Germany

Institute of Cancer and Genomic Sciences University of Birmingham Birmingham United Kingdom

Institute of Cell and Molecular Pathology Hannover Medical School Hannover Germany

Institute of Human Genetics Hannover Medical School Hannover Germany

Institute of Human Genetics University Hospital Heidelberg Heidelberg Germany

Institute of Human Genetics University Hospital Leipzig Leipzig Germany

Institute of Human Genetics University Hospital of Schleswig Holstein Campus Kiel Christian Albrechts University Kiel Kiel Germany

Institute of Human Genetics University of Münster Münster Germany

Institute of Medical Genetics and Applied Genomics University of Tübingen Tübingen Germany

Istituto Nazionale Tumori 'Giovanni Paolo 2 Bari Italy

Latvian Biomedical Research and Study Centre Riga Latvia

Magee Womens Hospital University of Pittsburgh School of Medicine Pittsburgh Pennsylvania

Medical Genetics Unit St George's University of London London United Kingdom

Medical Oncology Department Hospital Clínico San Carlos Instituto de Investigación Sanitaria San Carlos Madrid Spain

Molecular Diagnostic Unit Hereditary Cancer Program IDIBELL Catalan Institute of Oncology CIBERONC Barcelona Spain

Molecular Diagnostics Laboratory INRASTES National Centre for Scientific Research Demokritos Athens Greece

Molecular Genetics of Breast Cancer German Cancer Research Center Heidelberg Germany

Molecular Genetics of Breast Cancer German Cancer Research Center Heidelberg Germany Institute of Human Genetics Pontificia Universidad Javeriana Bogota Colombia

Molecular Genetics of Breast Cancer German Cancer Research Center Lahore Pakistan

North East Thames Regional Genetics Service Great Ormond Street Hospital for Children NHS Trust London United Kingdom

North West Thames Regional Genetics Service Kennedy Galton Centre The North West London Hospitals NHS Trust Middlesex United Kingdom

Oncogenetics Group Clinical and Molecular Genetics Area Vall d'Hebron Institute of Oncology University Hospital Barcelona Spain

Oncogenetics Team The Institute of Cancer Research and Royal Marsden NHS Foundation Trust Sutton United Kingdom

Parkville Familial Cancer Centre Peter MacCallum Cancer Center Melbourne Victoria Australia

Peter MacCallum Cancer Center Melbourne Victoria Australia Sir Peter MacCallum Department of Oncology The University of Melbourne Melbourne Victoria Australia

Precision Medicine School of Clinical Sciences at Monash Health Monash University Clayton Victoria Australia Department of Clinical Pathology The University of Melbourne Melbourne Victoria Australia

Program in Cancer Genetics Departments of Human Genetics and Oncology McGill University Montréal Quebec Canada Department of Medical Genetics University of Cambridge Cambridge United Kingdom

Section of Genetic Oncology Department of Laboratory Medicine University and University Hospital of Pisa Pisa Italy

Section of Molecular Diagnostics Clinical Biochemistry Aalborg University Hospital Aalborg Denmark

Section of Molecular Genetics Department of Laboratory Medicine University Hospital of Pisa Pisa Italy

Service de Biologie de la Reproduction Cytogénétique et Génétique Médicale CHI Poissy Saint Germain Poissy France

Service de Génétique Institut Curie Paris France

Service de Génétique Institut Curie Paris France Department of Tumour Biology INSERM U830 Paris France Université Paris Descartes Paris France

Service de Génétique Institut Curie Paris France Genetic Epidemiology of Cancer Team Inserm U900 Paris France Institut Curie Paris France Mines ParisTech Fontainebleau France

Service Régional Oncogénétique Poitou Charentes CH Niort Niort France

Sheffield Clinical Genetics Service Sheffield Children's Hospital Sheffield United Kingdom

Sir Peter MacCallum Department of Oncology The University of Melbourne Melbourne Victoria Australia Parkville Familial Cancer Centre Peter MacCallum Cancer Center Melbourne Victoria Australia

South East of Scotland Regional Genetics Service Western General Hospital Edinburgh United Kingdom

The Hereditary Breast and Ovarian Cancer Research Group Netherlands Coordinating center The Netherlands Cancer Institute Amsterdam the Netherlands

Translational Research Laboratory IDIBELL Catalan Institute of Oncology CIBERONC Barcelona Spain

ULSS 3 Serenissima U O C Oncologia ed Ematologia Oncologica Mirano Venice Italy

Unit of Hereditary Cancer Department of Epidemiology Prevention and Special Functions IRCCS AOU San Martino IST Istituto Nazionale per la Ricerca sul Cancro Genoa Italy

Unit of Medical Genetics Department of Medical Oncology and Hematology Fondazione IRCCS Istituto Nazionale dei Tumori di Milano Milan Italy

Unit of Molecular Bases of Genetic Risk and Genetic Testing Department of Research in Fondazione IRCCS Milan Italy

Unité d'oncogénétique Centre de Lutte Contre le Cancer Centre Georges François Leclerc Dijon France

Unité d'Oncogénétique Centre de Lutte Contre le Cancer Paul Strauss Strasbourg France

Unité de Prévention et d'Epidémiologie Génétique Centre Léon Bérard Lyon France

UO Anatomia Patologica Ospedale di Circolo Università dell'Insubria Varese Italy

West Midlands Regional Genetics Service Birmingham Women's Hospital Healthcare NHS Trust Birmingham United Kingdom

Yorkshire Regional Genetics Service Chapel Allerton Hospital Leeds United Kingdom

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20025213
003      
CZ-PrNML
005      
20201222155120.0
007      
ta
008      
201125s2020 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1158/0008-5472.CAN-19-1840 $2 doi
035    __
$a (PubMed)31723001
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Patel, Vivek L $u Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts.
245    10
$a Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness / $c VL. Patel, EL. Busch, TM. Friebel, A. Cronin, G. Leslie, L. McGuffog, J. Adlard, S. Agata, BA. Agnarsson, M. Ahmed, K. Aittomäki, E. Alducci, IL. Andrulis, A. Arason, N. Arnold, G. Artioli, B. Arver, B. Auber, J. Azzollini, J. Balmaña, RB. Barkardottir, DR. Barnes, A. Barroso, D. Barrowdale, M. Belotti, J. Benitez, B. Bertelsen, MJ. Blok, I. Bodrogi, V. Bonadona, B. Bonanni, D. Bondavalli, SE. Boonen, J. Borde, A. Borg, AR. Bradbury, A. Brady, C. Brewer, J. Brunet, B. Buecher, SS. Buys, S. Cabezas-Camarero, T. Caldés, A. Caliebe, MA. Caligo, M. Calvello, IG. Campbell, I. Carnevali, E. Carrasco, TL. Chan, ATW. Chu, WK. Chung, KBM. Claes, GS. Collaborators, E. Collaborators, J. Cook, L. Cortesi, FJ. Couch, MB. Daly, G. Damante, E. Darder, R. Davidson, M. de la Hoya, LD. Puppa, J. Dennis, O. Díez, YC. Ding, N. Ditsch, SM. Domchek, A. Donaldson, B. Dworniczak, DF. Easton, DM. Eccles, RA. Eeles, H. Ehrencrona, B. Ejlertsen, C. Engel, DG. Evans, L. Faivre, U. Faust, L. Feliubadaló, L. Foretova, F. Fostira, G. Fountzilas, D. Frost, V. García-Barberán, P. Garre, M. Gauthier-Villars, L. Géczi, A. Gehrig, AM. Gerdes, P. Gesta, G. Giannini, G. Glendon, AK. Godwin, DE. Goldgar, MH. Greene, AM. Gutierrez-Barrera, E. Hahnen, U. Hamann, J. Hauke, N. Herold, FBL. Hogervorst, E. Honisch, JL. Hopper, PJ. Hulick, K. Investigators, H. Investigators, L. Izatt, A. Jager, P. James, R. Janavicius, UB. Jensen, TD. Jensen, OT. Johannsson, EM. John, V. Joseph, E. Kang, K. Kast, JI. Kiiski, SW. Kim, Z. Kim, KP. Ko, I. Konstantopoulou, G. Kramer, L. Krogh, TA. Kruse, A. Kwong, M. Larsen, C. Lasset, C. Lautrup, C. Lazaro, J. Lee, JW. Lee, MH. Lee, J. Lemke, F. Lesueur, A. Liljegren, A. Lindblom, P. Llovet, A. Lopez-Fernández, I. Lopez-Perolio, V. Lorca, JT. Loud, ESK. Ma, PL. Mai, S. Manoukian, V. Mari, L. Martin, L. Matricardi, N. Mebirouk, V. Medici, HEJ. Meijers-Heijboer, A. Meindl, AR. Mensenkamp, C. Miller, DM. Gomes, M. Montagna, TM. Mooij, L. Moserle, E. Mouret-Fourme, AM. Mulligan, KL. Nathanson, M. Navratilova, H. Nevanlinna, D. Niederacher, FCC. Nielsen, L. Nikitina-Zake, K. Offit, E. Olah, OI. Olopade, KR. Ong, A. Osorio, CE. Ott, D. Palli, SK. Park, MT. Parsons, IS. Pedersen, B. Peissel, A. Peixoto, P. Pérez-Segura, P. Peterlongo, AH. Petersen, ME. Porteous, MA. Pujana, P. Radice, J. Ramser, J. Rantala, MU. Rashid, K. Rhiem, P. Rizzolo, ME. Robson, MA. Rookus, CM. Rossing, KJ. Ruddy, C. Santos, C. Saule, R. Scarpitta, RK. Schmutzler, H. Schuster, L. Senter, CM. Seynaeve, PD. Shah, P. Sharma, VY. Shin, V. Silvestri, J. Simard, CF. Singer, AB. Skytte, K. Snape, AR. Solano, P. Soucy, MC. Southey, AB. Spurdle, L. Steele, D. Steinemann, D. Stoppa-Lyonnet, A. Stradella, L. Sunde, C. Sutter, YY. Tan, MR. Teixeira, SH. Teo, M. Thomassen, MG. Tibiletti, M. Tischkowitz, S. Tognazzo, AE. Toland, S. Tommasi, D. Torres, A. Toss, AH. Trainer, N. Tung, CJ. van Asperen, FH. van der Baan, LE. van der Kolk, RB. van der Luijt, LP. van Hest, L. Varesco, R. Varon-Mateeva, A. Viel, J. Vierstraete, R. Villa, A. von Wachenfeldt, P. Wagner, S. Wang-Gohrke, B. Wappenschmidt, JN. Weitzel, G. Wieme, S. Yadav, D. Yannoukakos, SY. Yoon, C. Zanzottera, KK. Zorn, AV. D'Amico, ML. Freedman, MM. Pomerantz, G. Chenevix-Trench, AC. Antoniou, SL. Neuhausen, L. Ottini, HR. Nielsen, TR. Rebbeck,
520    9_
$a Pathogenic sequence variants (PSV) in BRCA1 or BRCA2 (BRCA1/2) are associated with increased risk and severity of prostate cancer. We evaluated whether PSVs in BRCA1/2 were associated with risk of overall prostate cancer or high grade (Gleason 8+) prostate cancer using an international sample of 65 BRCA1 and 171 BRCA2 male PSV carriers with prostate cancer, and 3,388 BRCA1 and 2,880 BRCA2 male PSV carriers without prostate cancer. PSVs in the 3' region of BRCA2 (c.7914+) were significantly associated with elevated risk of prostate cancer compared with reference bin c.1001-c.7913 [HR = 1.78; 95% confidence interval (CI), 1.25-2.52; P = 0.001], as well as elevated risk of Gleason 8+ prostate cancer (HR = 3.11; 95% CI, 1.63-5.95; P = 0.001). c.756-c.1000 was also associated with elevated prostate cancer risk (HR = 2.83; 95% CI, 1.71-4.68; P = 0.00004) and elevated risk of Gleason 8+ prostate cancer (HR = 4.95; 95% CI, 2.12-11.54; P = 0.0002). No genotype-phenotype associations were detected for PSVs in BRCA1. These results demonstrate that specific BRCA2 PSVs may be associated with elevated risk of developing aggressive prostate cancer. SIGNIFICANCE: Aggressive prostate cancer risk in BRCA2 mutation carriers may vary according to the specific BRCA2 mutation inherited by the at-risk individual.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a protein BRCA1 $x genetika $7 D019313
650    _2
$a protein BRCA2 $x genetika $7 D024682
650    _2
$a genetické asociační studie $7 D056726
650    12
$a genetická predispozice k nemoci $7 D020022
650    _2
$a genomika $x metody $7 D023281
650    _2
$a heterozygot $7 D006579
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    12
$a mutace $7 D009154
650    _2
$a prognóza $7 D011379
650    _2
$a nádory prostaty $x genetika $x patologie $7 D011471
650    _2
$a rizikové faktory $7 D012307
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a Research Support, N.I.H., Intramural $7 D052060
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a Research Support, U.S. Gov't, Non-P.H.S. $7 D013486
700    1_
$a Busch, Evan L $u Harvard T.H. Chan School of Public Health, Boston, Massachusetts. Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
700    1_
$a Friebel, Tara M $u Harvard T.H. Chan School of Public Health, Boston, Massachusetts. Dana-Farber Cancer Institute. Boston, Massachusetts.
700    1_
$a Cronin, Angel $u Dana-Farber Cancer Institute. Boston, Massachusetts.
700    1_
$a Leslie, Goska $u Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
700    1_
$a McGuffog, Lesley $u Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
700    1_
$a Adlard, Julian $u Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, United Kingdom.
700    1_
$a Agata, Simona $u Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
700    1_
$a Agnarsson, Bjarni A $u Department of Pathology, Landspitali University Hospital, 101, Reykjavik, Iceland. School of Medicine, University of Iceland, Reykjavik, Iceland.
700    1_
$a Ahmed, Munaza $u North East Thames Regional Genetics Service, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom.
700    1_
$a Aittomäki, Kristiina $u Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
700    1_
$a Alducci, Elisa $u Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
700    1_
$a Andrulis, Irene L $u Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada. Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
700    1_
$a Arason, Adalgeir $u Department of Pathology, Landspitali University Hospital, 101, Reykjavik, Iceland. BMC (Biomedical Centre), Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
700    1_
$a Arnold, Norbert $u Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany.
700    1_
$a Artioli, Grazia $u ULSS 3 Serenissima, U.O.C. Oncologia ed Ematologia Oncologica, Mirano, Venice, Italy.
700    1_
$a Arver, Brita $u Department of Oncology, Karolinska Institutet, Stockholm, Sweden.
700    1_
$a Auber, Bernd $u Institute of Human Genetics, Hannover Medical School, Hannover, Germany.
700    1_
$a Azzollini, Jacopo $u Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Istituto Nazionale dei Tumori di Milano, Milan, Italy.
700    1_
$a Balmaña, Judith $u High Risk and Cancer Prevention Group, Vall d'Hebron Institute of Oncology, University Hospital Vall d'Hebron, Barcelona, Spain.
700    1_
$a Barkardottir, Rosa B $u Department of Pathology, Landspitali University Hospital, 101, Reykjavik, Iceland. BMC (Biomedical Centre), Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
700    1_
$a Barnes, Daniel R $u Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
700    1_
$a Barroso, Alicia $u Human Genetics Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
700    1_
$a Barrowdale, Daniel $u Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
700    1_
$a Belotti, Muriel $u Service de Génétique, Institut Curie, Paris, France.
700    1_
$a Benitez, Javier $u Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain.
700    1_
$a Bertelsen, Birgitte $u Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
700    1_
$a Blok, Marinus J $u Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, the Netherlands.
700    1_
$a Bodrogi, Istvan $u Department of Chemotherapy, National Institute of Oncology, Budapest, Hungary.
700    1_
$a Bonadona, Valérie $u Unité de Prévention et d'Epidémiologie Génétique, Centre Léon Bérard, Lyon, France.
700    1_
$a Bonanni, Bernardo $u Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, Milan, Italy.
700    1_
$a Bondavalli, Davide $u Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, Milan, Italy.
700    1_
$a Boonen, Susanne E $u Clinical Genetic Unit, Department of Paediatrics, Zealand University Hospital, Roskilde, Denmark.
700    1_
$a Borde, Julika $u Center for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany. Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany. Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany.
700    1_
$a Borg, Ake $u Department of Oncology, Lund University and Skåne University Hospital, Lund, Sweden.
700    1_
$a Bradbury, Angela R $u Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
700    1_
$a Brady, Angela $u North West Thames Regional Genetics Service, Kennedy Galton Centre, The North West London Hospitals NHS Trust, Middlesex, United Kingdom.
700    1_
$a Brewer, Carole $u Department of Clinical Genetics, Royal Devon & Exeter Hospital, Exeter, United Kingdom.
700    1_
$a Brunet, Joan $u Genetic Counseling Unit, Hereditary Cancer Program, IDIBGI (Institut d'Investigació Biomèdica de Girona), Catalan Institute of Oncology, CIBERONC, Girona, Spain.
700    1_
$a Buecher, Bruno $u Service de Génétique, Institut Curie, Paris, France.
700    1_
$a Buys, Saundra S $u Department of Medicine, Huntsman Cancer Institute, Salt Lake City, Utah.
700    1_
$a Cabezas-Camarero, Santiago $u Department of Oncology, Hospital Clinico San Carlos, IdISSC, Madrid, Spain.
700    1_
$a Caldés, Trinidad $u Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
700    1_
$a Caliebe, Almuth $u Institute of Human Genetics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany.
700    1_
$a Caligo, Maria A $u Section of Molecular Genetics, Department of Laboratory Medicine, University Hospital of Pisa, Pisa, Italy.
700    1_
$a Calvello, Mariarosaria $u Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, Milan, Italy.
700    1_
$a Campbell, Ian G $u Peter MacCallum Cancer Center, Melbourne, Victoria, Australia. Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
700    1_
$a Carnevali, Ileana $u UO Anatomia Patologica, Ospedale di Circolo-Università dell'Insubria, Varese, Italy.
700    1_
$a Carrasco, Estela $u High Risk and Cancer Prevention Group, Vall d'Hebron Institute of Oncology, University Hospital Vall d'Hebron, Barcelona, Spain.
700    1_
$a Chan, Tsun L $u Hong Kong Hereditary Breast Cancer Family Registry, Cancer Genetics Centre, Happy Valley, Hong Kong. Department of Pathology, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong.
700    1_
$a Chu, Annie T W $u Hong Kong Hereditary Breast Cancer Family Registry, Cancer Genetics Centre, Happy Valley, Hong Kong.
700    1_
$a Chung, Wendy K $u Departments of Pediatrics and Medicine, Columbia University, New York, New York.
700    1_
$a Claes, Kathleen B M $u Centre for Medical Genetics, Ghent University, Ghent, Belgium.
700    1_
$a Collaborators, Gemo Study $u Service de Génétique, Institut Curie, Paris, France.
700    1_
$a Collaborators, Embrace $u Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
700    1_
$a Cook, Jackie $u Sheffield Clinical Genetics Service, Sheffield Children's Hospital, Sheffield, United Kingdom.
700    1_
$a Cortesi, Laura $u Department of Oncology and Haematology, University of Modena and Reggio Emilia, Modena, Italy.
700    1_
$a Couch, Fergus J $u Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
700    1_
$a Daly, Mary B $u Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
700    1_
$a Damante, Giuseppe $u Department of Medical and Biological Sciences, University of Udine, Udine, Italy.
700    1_
$a Darder, Esther $u Genetic Counseling Unit, Hereditary Cancer Program, IDIBGI (Institut d'Investigació Biomèdica de Girona), Catalan Institute of Oncology, CIBERONC, Girona, Spain.
700    1_
$a Davidson, Rosemarie $u Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, United Kingdom.
700    1_
$a de la Hoya, Miguel $u Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
700    1_
$a Puppa, Lara Della $u Division of Functional Onco-genomics and Genetics, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.
700    1_
$a Dennis, Joe $u Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
700    1_
$a Díez, Orland $u Oncogenetics Group, Clinical and Molecular Genetics Area, Vall d'Hebron Institute of Oncology (VHIO), University Hospital, Barcelona, Spain.
700    1_
$a Ding, Yuan Chun $u Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California.
700    1_
$a Ditsch, Nina $u Department of Gynecology and Obstetrics, Ludwig Maximilian University of Munich, Munich, Germany.
700    1_
$a Domchek, Susan M $u Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
700    1_
$a Donaldson, Alan $u Clinical Genetics Department, St Michael's Hospital, Bristol, United Kingdom.
700    1_
$a Dworniczak, Bernd $u Institute of Human Genetics, University of Münster, Münster, Germany.
700    1_
$a Easton, Douglas F $u Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom. Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.
700    1_
$a Eccles, Diana M $u Cancer Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
700    1_
$a Eeles, Rosalind A $u Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom.
700    1_
$a Ehrencrona, Hans $u Department of Clinical Genetics, Lund University Hospital, Lund, Sweden.
700    1_
$a Ejlertsen, Bent $u Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
700    1_
$a Engel, Christoph $u Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany. LIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
700    1_
$a Evans, D Gareth $u Division of Evolution and Genomic Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health and Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom. Manchester Centre for Genomic Medicine, St Mary's Hospital, Central Manchester University Hospitals NHS Foundation Trust and Manchester Academic Health Science Centre, Manchester, United Kingdom.
700    1_
$a Faivre, Laurence $u Unité d'oncogénétique, Centre de Lutte Contre le Cancer, Centre Georges-François Leclerc, Dijon, France.
700    1_
$a Faust, Ulrike $u Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.
700    1_
$a Feliubadaló, Lídia $u Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL (Bellvitge Biomedical Research Institute), Catalan Institute of Oncology, CIBERONC, Barcelona, Spain.
700    1_
$a Foretova, Lenka $u Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
700    1_
$a Fostira, Florentia $u Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research "Demokritos", Athens, Greece.
700    1_
$a Fountzilas, George $u Second Department of Medical Oncology, EUROMEDICA General Clinic of Thessaloniki, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece.
700    1_
$a Frost, Debra $u Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
700    1_
$a García-Barberán, Vanesa $u Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
700    1_
$a Garre, Pilar $u Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
700    1_
$a Gauthier-Villars, Marion $u Service de Génétique, Institut Curie, Paris, France.
700    1_
$a Géczi, Lajos $u Department of Chemotherapy, National Institute of Oncology, Budapest, Hungary.
700    1_
$a Gehrig, Andrea $u Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University of Würzburg, Würzburg, Germany.
700    1_
$a Gerdes, Anne-Marie $u Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark.
700    1_
$a Gesta, Paul $u Service Régional Oncogénétique Poitou-Charentes, CH Niort, Niort, France.
700    1_
$a Giannini, Giuseppe $u Department of Molecular Medicine, University La Sapienza, Rome, Italy.
700    1_
$a Glendon, Gord $u Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada.
700    1_
$a Godwin, Andrew K $u Department of Pathology and Laboratory Medicine, Kansas University Medical Center, Kansas City, Kansas.
700    1_
$a Goldgar, David E $u Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah.
700    1_
$a Greene, Mark H $u Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.
700    1_
$a Gutierrez-Barrera, Angelica M $u Department of Breast Medical Oncology and Clinical Genetics Program, University of Texas MD Anderson Cancer Center, Houston, Texas.
700    1_
$a Hahnen, Eric $u Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany. Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany.
700    1_
$a Hamann, Ute $u Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
700    1_
$a Hauke, Jan $u Center for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany. Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany. Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany.
700    1_
$a Herold, Natalie $u Center for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany. Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany. Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany.
700    1_
$a Hogervorst, Frans B L $u Family Cancer Clinic, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
700    1_
$a Honisch, Ellen $u Department of Gynecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.
700    1_
$a Hopper, John L $u Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
700    1_
$a Hulick, Peter J $u Center for Medical Genetics, NorthShore University HealthSystem, Evanston, Illinois. The University of Chicago Pritzker School of Medicine, Chicago, Illinois.
700    1_
$a Investigators, KConFab $u Peter MacCallum Cancer Center, Melbourne, Victoria, Australia. Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
700    1_
$a Investigators, Hebon $u The Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Coordinating center: The Netherlands Cancer Institute, Amsterdam, the Netherlands.
700    1_
$a Izatt, Louise $u Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
700    1_
$a Jager, Agnes $u Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
700    1_
$a James, Paul $u Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia. Parkville Familial Cancer Centre, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.
700    1_
$a Janavicius, Ramunas $u Hematology, Oncology and Transfusion Medicine Center, Department of Molecular and Regenerative Medicine, Vilnius University Hospital Santariskiu Clinics, Vilnius, Lithuania.
700    1_
$a Jensen, Uffe Birk $u Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark.
700    1_
$a Jensen, Thomas Dyrso $u Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark.
700    1_
$a Johannsson, Oskar Th $u Department of Oncology, Landspitali University Hospital, Reykjavik, Iceland.
700    1_
$a John, Esther M $u Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.
700    1_
$a Joseph, Vijai $u Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, New York.
700    1_
$a Kang, Eunyoung $u Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Korea.
700    1_
$a Kast, Karin $u Department of Gynecology and Obstetrics, Technical University of Dresden, Dresden, Germany.
700    1_
$a Kiiski, Johanna I $u Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
700    1_
$a Kim, Sung-Won $u Department of Surgery, Daerim Saint Mary's Hospital, Seoul, Korea.
700    1_
$a Kim, Zisun $u Department of Surgery, Soonchunhyang University Bucheon Hospital, Bucheon, Korea.
700    1_
$a Ko, Kwang-Pil $u Department of Preventive Medicine, Gacheon University College of Medicine, Incheon, Republic of Korea.
700    1_
$a Konstantopoulou, Irene $u Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research "Demokritos", Athens, Greece.
700    1_
$a Kramer, Gero $u Department of Urology, Medical University of Vienna, Vienna, Austria.
700    1_
$a Krogh, Lotte $u Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.
700    1_
$a Kruse, Torben A $u Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.
700    1_
$a Kwong, Ava $u Hong Kong Hereditary Breast Cancer Family Registry, Cancer Genetics Centre, Happy Valley, Hong Kong. Department of Surgery, The University of Hong Kong, Pok Fu Lam, Hong Kong. Department of Surgery, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong.
700    1_
$a Larsen, Mirjam $u Center for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany. Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany. Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany.
700    1_
$a Lasset, Christine $u Unité de Prévention et d'Epidémiologie Génétique, Centre Léon Bérard, Lyon, France.
700    1_
$a Lautrup, Charlotte $u Department of Clinical Genetics, Aalborg University Hospital, Aalborg, Denmark.
700    1_
$a Lazaro, Conxi $u Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL (Bellvitge Biomedical Research Institute), Catalan Institute of Oncology, CIBERONC, Barcelona, Spain.
700    1_
$a Lee, Jihyoun $u Department of Surgery, Soonchunhyang University College of Medicine and Soonchunhyang University Hospital, Seoul, Korea.
700    1_
$a Lee, Jong Won $u Department of Surgery, Ulsan University College of Medicine and Asan Medical Center, Seoul, Korea.
700    1_
$a Lee, Min Hyuk $u Department of Surgery, Soonchunhyang University College of Medicine and Soonchunhyang University Hospital, Seoul, Korea.
700    1_
$a Lemke, Johannes $u Institute of Human Genetics, University Hospital Leipzig, Leipzig, Germany.
700    1_
$a Lesueur, Fabienne $u Service de Génétique, Institut Curie, Paris, France. Genetic Epidemiology of Cancer Team, Inserm U900, Paris, France. Institut Curie, Paris, France. Mines ParisTech, Fontainebleau, France.
700    1_
$a Liljegren, Annelie $u Department of Oncology, Karolinska Institutet, Stockholm, Sweden.
700    1_
$a Lindblom, Annika $u Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden. Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.
700    1_
$a Llovet, Patricia $u Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
700    1_
$a Lopez-Fernández, Adria $u High Risk and Cancer Prevention Group, Vall d'Hebron Institute of Oncology, University Hospital Vall d'Hebron, Barcelona, Spain.
700    1_
$a Lopez-Perolio, Irene $u Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
700    1_
$a Lorca, Victor $u Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.
700    1_
$a Loud, Jennifer T $u Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.
700    1_
$a Ma, Edmond S K $u Hong Kong Hereditary Breast Cancer Family Registry, Cancer Genetics Centre, Happy Valley, Hong Kong. Department of Pathology, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong.
700    1_
$a Mai, Phuong L $u Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
700    1_
$a Manoukian, Siranoush $u Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Istituto Nazionale dei Tumori di Milano, Milan, Italy.
700    1_
$a Mari, Veronique $u Département d'Hématologie-Oncologie Médicale, Centre Antoine Lacassagne, Nice, France.
700    1_
$a Martin, Lynn $u Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
700    1_
$a Matricardi, Laura $u Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
700    1_
$a Mebirouk, Noura $u Service de Génétique, Institut Curie, Paris, France. Genetic Epidemiology of Cancer Team, Inserm U900, Paris, France. Institut Curie, Paris, France. Mines ParisTech, Fontainebleau, France.
700    1_
$a Medici, Veronica $u Department of Oncology and Haematology, University of Modena and Reggio Emilia, Modena, Italy.
700    1_
$a Meijers-Heijboer, Hanne E J $u Department of Clinical Genetics, VU University Medical Center, Amsterdam, the Netherlands.
700    1_
$a Meindl, Alfons $u Department of Gynecology and Obstetrics, Ludwig Maximilian University of Munich, Munich, Germany.
700    1_
$a Mensenkamp, Arjen R $u Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.
700    1_
$a Miller, Clare $u Department of Clinical Genetics, Alder Hey Hospital, Liverpool, United Kingdom.
700    1_
$a Gomes, Denise Molina $u Service de Biologie de la Reproduction, Cytogénétique et Génétique Médicale, CHI Poissy - Saint Germain, Poissy, France.
700    1_
$a Montagna, Marco $u Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
700    1_
$a Mooij, Thea M $u Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
700    1_
$a Moserle, Lidia $u Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
700    1_
$a Mouret-Fourme, Emmanuelle $u Service de Génétique, Institut Curie, Paris, France.
700    1_
$a Mulligan, Anna Marie $u Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada. Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada.
700    1_
$a Nathanson, Katherine L $u Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
700    1_
$a Navratilova, Marie $u Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
700    1_
$a Nevanlinna, Heli $u Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
700    1_
$a Niederacher, Dieter $u Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
700    1_
$a Nielsen, Finn C Cilius $u Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
700    1_
$a Nikitina-Zake, Liene $u Latvian Biomedical Research and Study Centre, Riga, Latvia.
700    1_
$a Offit, Kenneth $u Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Korea. Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York.
700    1_
$a Olah, Edith $u Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary.
700    1_
$a Olopade, Olufunmilayo I $u Center for Clinical Cancer Genetics, The University of Chicago, Chicago, Illinois.
700    1_
$a Ong, Kai-Ren $u West Midlands Regional Genetics Service, Birmingham Women's Hospital Healthcare NHS Trust, Birmingham, United Kingdom.
700    1_
$a Osorio, Ana $u Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain.
700    1_
$a Ott, Claus-Eric $u Institute for Medical Genetics and Human Genetics, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
700    1_
$a Palli, Domenico $u Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.
700    1_
$a Park, Sue K $u Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea. Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, Korea. Cancer Research Institute, Seoul National University, Seoul, Korea.
700    1_
$a Parsons, Michael T $u Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
700    1_
$a Pedersen, Inge Sokilde $u Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark.
700    1_
$a Peissel, Bernard $u Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Istituto Nazionale dei Tumori di Milano, Milan, Italy.
700    1_
$a Peixoto, Ana $u Department of Genetics, Portuguese Oncology Institute, Porto, Portugal.
700    1_
$a Pérez-Segura, Pedro $u Department of Oncology, Hospital Clinico San Carlos, IdISSC, Madrid, Spain.
700    1_
$a Peterlongo, Paolo $u Genome Diagnostics Program, IFOM - the FIRC (Italian Foundation for Cancer Research) Institute of Molecular Oncology, Milan, Italy.
700    1_
$a Petersen, Annabeth Høgh $u Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark.
700    1_
$a Porteous, Mary E $u South East of Scotland Regional Genetics Service, Western General Hospital, Edinburgh, United Kingdom.
700    1_
$a Pujana, Miguel Angel $u Translational Research Laboratory, IDIBELL (Bellvitge Biomedical Research Institute), Catalan Institute of Oncology, CIBERONC, Barcelona, Spain.
700    1_
$a Radice, Paolo $u Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, in Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy.
700    1_
$a Ramser, Juliane $u Division of Gynaecology and Obstetrics, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany.
700    1_
$a Rantala, Johanna $u Clinical Genetics, Karolinska Institutet, Stockholm, Sweden.
700    1_
$a Rashid, Muhammad U $u Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. Department of Basic Sciences, Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH & RC), Lahore, Pakistan.
700    1_
$a Rhiem, Kerstin $u Center for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany. Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany. Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany.
700    1_
$a Rizzolo, Piera $u Department of Molecular Medicine, University La Sapienza, Rome, Italy.
700    1_
$a Robson, Mark E $u Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York.
700    1_
$a Rookus, Matti A $u Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
700    1_
$a Rossing, Caroline M $u Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
700    1_
$a Ruddy, Kathryn J $u Department of Oncology, Mayo Clinic, Rochester, Minnesota.
700    1_
$a Santos, Catarina $u Department of Genetics, Portuguese Oncology Institute, Porto, Portugal.
700    1_
$a Saule, Claire $u Service de Génétique, Institut Curie, Paris, France.
700    1_
$a Scarpitta, Rosa $u Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa, Italy.
700    1_
$a Schmutzler, Rita K $u Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany. Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany.
700    1_
$a Schuster, Hélène $u Unité d'Oncogénétique, Centre de Lutte Contre le Cancer Paul Strauss, Strasbourg, France.
700    1_
$a Senter, Leigha $u Clinical Cancer Genetics Program, Division of Human Genetics, Department of Internal Medicine, The Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
700    1_
$a Seynaeve, Caroline M $u Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
700    1_
$a Shah, Payal D $u Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
700    1_
$a Sharma, Priyanka $u Department of Internal Medicine, Division of Oncology, University of Kansas Medical Center, Westwood, Kansas.
700    1_
$a Shin, Vivian Y $u Department of Surgery, The University of Hong Kong, Pok Fu Lam, Hong Kong.
700    1_
$a Silvestri, Valentina $u Department of Molecular Medicine, University La Sapienza, Rome, Italy.
700    1_
$a Simard, Jacques $u Genomics Center, Centre Hospitalier Universitaire de Québec - Université Laval, Research Centre, Québec City, Québec, Canada.
700    1_
$a Singer, Christian F $u Dept of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
700    1_
$a Skytte, Anne-Bine $u Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark.
700    1_
$a Snape, Katie $u Medical Genetics Unit, St George's, University of London, London, United Kingdom.
700    1_
$a Solano, Angela R $u INBIOMED, Faculty of Medicine/CONICET and CEMIC, Department of Clinical Chemistry, Medical Direction, University of Buenos Aires, Buenos Aires, Argentina.
700    1_
$a Soucy, Penny $u Department of Internal Medicine, Division of Oncology, University of Kansas Medical Center, Westwood, Kansas.
700    1_
$a Southey, Melissa C $u Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia. Department of Clinical Pathology, The University of Melbourne, Melbourne, Victoria, Australia.
700    1_
$a Spurdle, Amanda B $u Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
700    1_
$a Steele, Linda $u Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California.
700    1_
$a Steinemann, Doris $u Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany.
700    1_
$a Stoppa-Lyonnet, Dominique $u Service de Génétique, Institut Curie, Paris, France. Department of Tumour Biology, INSERM U830, Paris, France. Université Paris Descartes, Paris, France.
700    1_
$a Stradella, Agostina $u Genetic Counseling Unit, Hereditary Cancer Program, IDIBELL (Bellvitge Biomedical Research Institute), Catalan Institute of Oncology, CIBERONC, Barcelona, Spain.
700    1_
$a Sunde, Lone $u Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark.
700    1_
$a Sutter, Christian $u Institute of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany.
700    1_
$a Tan, Yen Y $u Department of OB/GYN, Medical University of Vienna, Vienna, Austria.
700    1_
$a Teixeira, Manuel R $u Department of Genetics, Portuguese Oncology Institute, Porto, Portugal. Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal.
700    1_
$a Teo, Soo Hwang $u Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia. Breast Cancer Research Unit, Cancer Research Institute, University Malaya Medical Centre, Kuala Lumpur, Malaysia.
700    1_
$a Thomassen, Mads $u Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.
700    1_
$a Tibiletti, Maria Grazia $u UO Anatomia Patologica, Ospedale di Circolo-Università dell'Insubria, Varese, Italy.
700    1_
$a Tischkowitz, Marc $u Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montréal, Quebec, Canada. Department of Medical Genetics, University of Cambridge, Cambridge, United Kingdom.
700    1_
$a Tognazzo, Silvia $u Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.
700    1_
$a Toland, Amanda E $u Department of Cancer Biology and Genetics, The Ohio State University, Columbus, Ohio.
700    1_
$a Tommasi, Stefania $u Istituto Nazionale Tumori 'Giovanni Paolo II, Bari, Italy.
700    1_
$a Torres, Diana $u Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany. Institute of Human Genetics, Pontificia Universidad Javeriana, Bogota, Colombia.
700    1_
$a Toss, Angela $u Department of Oncology and Haematology, University of Modena and Reggio Emilia, Modena, Italy.
700    1_
$a Trainer, Alison H $u Parkville Familial Cancer Centre, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.
700    1_
$a Tung, Nadine $u Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
700    1_
$a van Asperen, Christi J $u Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands.
700    1_
$a van der Baan, Frederieke H $u Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
700    1_
$a van der Kolk, Lizet E $u Family Cancer Clinic, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
700    1_
$a van der Luijt, Rob B $u Department of Medical Genetics, University Medical Center, Utrecht, the Netherlands.
700    1_
$a van Hest, Liselotte P $u Clinical Genetics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
700    1_
$a Varesco, Liliana $u Unit of Hereditary Cancer, Department of Epidemiology, Prevention and Special Functions, IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) AOU San Martino, IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy.
700    1_
$a Varon-Mateeva, Raymonda $u Institute for Medical Genetics and Human Genetics, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
700    1_
$a Viel, Alessandra $u Division of Functional Onco-genomics and Genetics, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.
700    1_
$a Vierstraete, Jeroen $u Centre for Medical Genetics, Ghent University, Ghent, Belgium.
700    1_
$a Villa, Roberta $u Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Istituto Nazionale dei Tumori di Milano, Milan, Italy.
700    1_
$a von Wachenfeldt, Anna $u Department of Oncology, Karolinska Institutet, Stockholm, Sweden.
700    1_
$a Wagner, Philipp $u Department of Women's Health, Tubingen University Hospital, Tubingen, Germany.
700    1_
$a Wang-Gohrke, Shan $u Department of Gynaecology and Obstetrics, University Hospital Ulm, Ulm, Germany.
700    1_
$a Wappenschmidt, Barbara $u Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany. Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany.
700    1_
$a Weitzel, Jeffrey N $u Clinical Cancer Genetics, City of Hope, Duarte, California.
700    1_
$a Wieme, Greet $u Centre for Medical Genetics, Ghent University, Ghent, Belgium.
700    1_
$a Yadav, Siddhartha $u Department of Oncology, Mayo Clinic, Rochester, Minnesota.
700    1_
$a Yannoukakos, Drakoulis $u Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research "Demokritos", Athens, Greece.
700    1_
$a Yoon, Sook-Yee $u Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Selangor, Malaysia.
700    1_
$a Zanzottera, Cristina $u Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Istituto Nazionale dei Tumori di Milano, Milan, Italy.
700    1_
$a Zorn, Kristin K $u Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
700    1_
$a D'Amico, Anthony V $u Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts.
700    1_
$a Freedman, Matthew L $u Dana-Farber Cancer Institute. Boston, Massachusetts.
700    1_
$a Pomerantz, Mark M $u Dana-Farber Cancer Institute. Boston, Massachusetts.
700    1_
$a Chenevix-Trench, Georgia $u Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
700    1_
$a Antoniou, Antonis C $u Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
700    1_
$a Neuhausen, Susan L $u Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California.
700    1_
$a Ottini, Laura $u Department of Molecular Medicine, University La Sapienza, Rome, Italy.
700    1_
$a Nielsen, Henriette Roed $u Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.
700    1_
$a Rebbeck, Timothy R $u Harvard T.H. Chan School of Public Health, Boston, Massachusetts. Timothy_Rebbeck@dfci.harvard.edu. Dana-Farber Cancer Institute. Boston, Massachusetts.
773    0_
$w MED00009437 $t Cancer research $x 1538-7445 $g Roč. 80, č. 3 (2020), s. 624-638
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31723001 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201222155114 $b ABA008
999    __
$a ok $b bmc $g 1599358 $s 1115899
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 80 $c 3 $d 624-638 $e 20191113 $i 1538-7445 $m Cancer research $n Cancer Res $x MED00009437
GRA    __
$a 203477/Z/16/Z $p Wellcome Trust $2 United Kingdom
GRA    __
$a CRN-87521 $p CIHR $2 Canada
GRA    __
$a C1287/A 10710 $p Cancer Research UK $2 United Kingdom
GRA    __
$a P50 CA116201 $p NCI NIH HHS $2 United States
GRA    __
$a R01 CA149429 $p NCI NIH HHS $2 United States
GRA    __
$a U19 CA148065 $p NCI NIH HHS $2 United States
GRA    __
$a C1281/A12014 $p Cancer Research UK $2 United Kingdom
GRA    __
$a U10 CA180822 $p NCI NIH HHS $2 United States
GRA    __
$a U10 CA180868 $p NCI NIH HHS $2 United States
GRA    __
$a R03 CA130065 $p NCI NIH HHS $2 United States
GRA    __
$a R01 CA176785 $p NCI NIH HHS $2 United States
GRA    __
$a CRN-87521 $p CIHR $2 Canada
GRA    __
$a RC4 CA153828 $p NCI NIH HHS $2 United States
GRA    __
$a P20 CA233255 $p NCI NIH HHS $2 United States
GRA    __
$a R01 CA142996 $p NCI NIH HHS $2 United States
GRA    __
$a R01 CA140323 $p NCI NIH HHS $2 United States
GRA    __
$a P50 CA125183 $p NCI NIH HHS $2 United States
GRA    __
$a UM1 CA164920 $p NCI NIH HHS $2 United States
GRA    __
$a P30 CA168524 $p NCI NIH HHS $2 United States
GRA    __
$a U01 CA161032 $p NCI NIH HHS $2 United States
GRA    __
$a C12292/A11174 $p Cancer Research UK $2 United Kingdom
GRA    __
$a U10 CA027469 $p NCI NIH HHS $2 United States
GRA    __
$a C5047/A10692 $p Cancer Research UK $2 United Kingdom
GRA    __
$a UL1 TR000124 $p NCATS NIH HHS $2 United States
GRA    __
$a U01 CA116167 $p NCI NIH HHS $2 United States
GRA    __
$a C5047/A8384 $p Cancer Research UK $2 United Kingdom
GRA    __
$a P30 CA008748 $p NCI NIH HHS $2 United States
GRA    __
$a R01 CA214545 $p NCI NIH HHS $2 United States
GRA    __
$a C5047/A8385FCCC $p Cancer Research UK $2 United Kingdom
GRA    __
$a R01 CA128978 $p NCI NIH HHS $2 United States
GRA    __
$a U19 CA148537 $p NCI NIH HHS $2 United States
GRA    __
$a P30 CA051008 $p NCI NIH HHS $2 United States
GRA    __
$a R01 CA116167 $p NCI NIH HHS $2 United States
GRA    __
$a C12292/A20861 $p Cancer Research UK $2 United Kingdom
GRA    __
$a U10 CA037517 $p NCI NIH HHS $2 United States
GRA    __
$a P20 GM130423 $p NIGMS NIH HHS $2 United States
GRA    __
$a R25 CA112486 $p NCI NIH HHS $2 United States
GRA    __
$a C5047/A15007 $p Cancer Research UK $2 United Kingdom
GRA    __
$a N02CP65504 $p NCI NIH HHS $2 United States
GRA    __
$a P50 CA105641 $p NCI NIH HHS $2 United States
GRA    __
$a T32 CA009001 $p NCI NIH HHS $2 United States
GRA    __
$a U19 CA148112 $p NCI NIH HHS $2 United States
GRA    __
$a C8197/A16565 $p Cancer Research UK $2 United Kingdom
GRA    __
$a 10118 $p Cancer Research UK $2 United Kingdom
GRA    __
$a R01 CA192393 $p NCI NIH HHS $2 United States
GRA    __
$a C12292/A11174 $p Cancer Research UK $2 United Kingdom
GRA    __
$a N02CP11019 $p NCI NIH HHS $2 United States
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...